|
1
|
IARC: International agency for research on
cancer: GLOBOCAN report. 2012.
|
|
2
|
Bosch FX, Lorincz A, Muñoz N, Meijer CJ
and Shah KV: The causal relation between human papillomavirus and
cervical cancer. J Clin Pathol. 55:244–265. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Walboomers JM, Jacobs MV, Manos MM, Bosch
FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ and Muñoz N:
Human papillomavirus is a necessary cause of invasive cervical
cancer worldwide. J Pathol. 189:12–19. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Anorlu RI: Cervical cancer: the
sub-Saharan African perspective. Reprod Health Matters. 16:41–49.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sitas F, Parkin DM, Chirenje M, Stein L,
Abratt R and Wabinga H: Part II: Cancer in indigenous
africans-causes and control. Lancet Oncol. 9:786–795. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
DOHSA: South African department of health;
2014
|
|
7
|
Woodman CB, Collins SI and Young LS: The
natural history of cervical HPV infection: Unresolved issues. Nat
Rev Cancer. 7:11–22. 2007. View
Article : Google Scholar
|
|
8
|
Magnusson PK, Lichtenstein P and
Gyllensten UB: Heritability of cervical tumours. Int J Cancer.
88:698–701. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang M, Chu H, Wang S, Wang M, Wang W, Han
S and Zhang Z: Genetic variant in APE1 gene promoter contributes to
cervical cancer risk. Am J Obstet Gynecol. 209:360 e1–7. 2013.
View Article : Google Scholar
|
|
10
|
Pérez LO, Crivaro A, Barbisan G, Poleri L
and Golijow CD: XRCC2 R188H (rs3218536), XRCC3 T241 M (rs861539)
and R243H (rs77381814) single nucleotide polymorphisms in cervical
cancer risk. Pathol Oncol Res. 19:553–558. 2013. View Article : Google Scholar
|
|
11
|
Bajpai D, Banerjee A, Pathak S, Jain SK
and Singh N: Decreased expression of DNA repair genes (XRCC1,
ERCC1, ERCC2 and ERCC4) in squamous intraepithelial lesion and
invasive squamous cell carcinoma of the cervix. Mol Cell Biochem.
377:45–53. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Oliveira S, Ribeiro J, Sousa H, Pinto D,
Baldaque I and Medeiros R: Genetic polymorphisms and cervical
cancer development: ATM G5557A and p53bp1 C1236 G. Oncol Rep.
27:1188–1192. 2012.
|
|
13
|
Jeggo P and Lavin MF: Cellular
radiosensitivity: How much better do we understand it? Int J Radiat
Biol. 85:1061–1081. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huo YK, Wang Z, Hong JH, Chessa L, McBride
WH, Perlman SL and Gatti RA: Radiosensitivity of
ataxia-telangiectasia, X-linked agammaglobulinemia and related
syndromes using a modified colony survival assay. Cancer Res.
54:2544–2547. 1994.PubMed/NCBI
|
|
15
|
Jones LA, Scott D, Cowan R and Roberts SA:
Abnormal radio-sensitivity of lymphocytes from breast cancer
patients with excessive normal tissue damage after radiotherapy:
chromosome aberrations after low dose-rate irradiation. Int J
Radiat Biol. 67:519–528. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Parshad R, Sanford KK and Jones GM:
Chromatid damage after G2 phase x-irradiation of cells from
cancer-prone individuals implicates deficiency in DNA repair. Proc
Natl Acad Sci USA. 80:5612–5616. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Baeyens A, Thierens H, Claes K, Poppe B,
Messiaen L, De Ridder L and Vral A: Chromosomal radiosensitivity in
breast cancer patients with a known or putative genetic
predisposition. Br J Cancer. 87:1379–1385. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Riches AC, Bryant PE, Steel CM, Gleig A,
Robertson AJ, Preece PE and Thompson AM: Chromosomal
radiosensitivity in G2-phase lymphocytes identifies breast cancer
patients with distinctive tumour characteristics. Br J Cancer.
85:1157–1161. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Terzoudi GI, Jung T, Hain J, Vrouvas J,
Margaritis K, Donta-Bakoyianni C, Makropoulos V, Angelakis P and
Pantelias GE: Increased G2 chromosomal radiosensitivity in cancer
patients: The role of cdk1/cyclin-B activity level in the
mechanisms involved. Int J Radiat Biol. 76:607–615. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Scott D, Spreadborough A, Levine E and
Roberts SA: Genetic predisposition in breast cancer. Lancet.
344:14441994. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Baria K, Warren C, Roberts SA, West CM and
Scott D: Chromosomal radiosensitivity as a marker of predisposition
to common cancers? Br J Cancer. 84:892–896. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ban S, Konomi C, Iwakawa M, Yamada S, Ohno
T, Tsuji H, Noda S, Matui Y, Harada Y, Cologne JB and Imai T:
Radiosensitivity of peripheral blood lymphocytes obtained from
patients with cancers of the breast, head and neck or cervix as
determined with a micronucleus assay. J Radiat Res. 45:535–541.
2004. View Article : Google Scholar
|
|
23
|
Bozsakyová E, Wsólová L and Chalupa I:
Spontaneous and gamma-ray-induced sister chromatid exchanges in
patients with carcinoma of cervix uteri. Int J Radiat Biol.
81:177–185. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gabelova A, Farkasova T, Gurska S,
Machackova Z, Lukacko P and Witkovsky V: Radiosensitivity of
peripheral blood lymphocytes from healthy donors and cervical
cancer patients; the correspondence of in vitro data with the
clinical outcome. Neoplasma. 55:182–191. 2008.PubMed/NCBI
|
|
25
|
Schunck C, Johannes T, Varga D, Lörch T
and Plesch A: New developments in automated cytogenetic imaging:
Unattended scoring of dicentric chromosomes, micronuclei, single
cell gel electrophoresis and fluorescence signals. Cytogenet Genome
Res. 104:383–389. 2004. View Article : Google Scholar
|
|
26
|
Bolognesi C, Balia C, Roggieri P, et al:
Micronucleus test for radiation biodosimetry in mass casualty
events: Evaluation of visual and automated scoring. Radiation
Measurements. 46:169–175. 2011. View Article : Google Scholar
|
|
27
|
Baeyens A, Swanson R, Herd O, Ainsbury E,
Mabhengu T, Willem P, Thierens H, Slabbert JP and Vral A: A
semi-automated micronucleus-centromere assay to assess low-dose
radiation exposure in human lymphocytes. Int J Radiat Biol.
87:923–931. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Varga D, Johannes T, Jainta S, Schuster S,
Schwarz-Boeger U, Kiechle M, Patino Garcia B and Vogel W: An
automated scoring procedure for the micronucleus test by image
analysis. Mutagenesis. 19:391–397. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fenech M, Kirsch-Volders M, Rossnerova A,
Sram R, Romm H, Bolognesi C, Ramakumar A, Soussaline F, Schunck C
and Elhajouji A: HUMN project initiative and review of validation,
quality control and prospects for further development of automated
micronucleus assays using image cytometry systems. Int J Hyg
Environ Health. 216:541–552. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Varga D, Michel I, Patino-Garcia B, Paiss
T, Vogel W and Maier C: Radiosensitivity detected by the
micronucleus test is not generally increased in sporadic prostate
cancer patients. Cytogenet Genome Res. 111:41–45. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Varga D, Hoegel J, Maier C, Jainta S,
Hoehne M, Patino-Garcia B, Michel I, Schwarz-Boeger U, Kiechle M,
Kreienberg R and Vogel W: On the difference of micronucleus
frequencies in peripheral blood lymphocytes between breast cancer
patients and controls. Mutagenesis. 21:313–320. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Willems P, August L, Slabbert J, Romm H,
Oestreicher U, Thierens H and Vral A: Automated micronucleus (MN)
scoring for population triage in case of large scale radiation
events. Int J Radiat Biol. 86:2–11. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Baeyens A, Slabbert JP, Willem P, Jozela
S, Van Der Merwe D and Vral A: Chromosomal radiosensitivity of HIV
positive individuals. Int J Radiat Biol. 86:584–592. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
STATSSA: Statistics South Africa: Mid-year
population estimates South Africa. 2013.
|
|
35
|
CDC: Centre for disease control:
Classification system for HIV infection and expanded surveillance
case definition for AIDS among adolescents and adults. 1993.
|
|
36
|
Firnhaber C, Van Le H, Pettifor A, Schulze
D, Michelow P, Sanne IM, Lewis DA, Williamson AL, Allan B, Williams
S, et al: Association between cervical dysplasia and human
papillomavirus in HIV seropositive women from Johannesburg South
Africa. Cancer Causes Control. 21:433–443. 2010. View Article : Google Scholar :
|
|
37
|
Heard I, Schmitz V, Costagliola D, Orth G
and Kazatchkine MD: Early regression of cervical lesions in
HIV-seropositive women receiving highly active antiretroviral
therapy. AIDS. 12:1459–1464. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Thierens H, Vral A, Vandevoorde C,
Vandersickel V, de Gelder V, Romm H, Oestreicher U, Rothkamm K,
Barnard S, Ainsbury E4, et al: Is a semi-automated approach
indicated in the application of the automated micronucleus assay
for triage purposes? Radiat Prot Dosimetry. 159:87–94. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Encheva E, Deleva S, Hristova R,
Hadjidekova V and Hadjieva T: Investigating micronucleus assay
applicability for prediction of normal tissue intrinsic
radiosensitivity in gynecological cancer patients. Rep Pract Oncol
Radiother. 17:24–31. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Magnusson PK, Sparén P and Gyllensten UB:
Genetic link to cervical tumours. Nature. 400:29–30. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chen D, Hammer J, Lindquist D, Idahl A and
Gyllensten U: A variant upstream of HLA-DRB1 and multiple variants
in MICA influence susceptibility to cervical cancer in a Swedish
population. Cancer Med. 3:190–198. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Jiang J, Li N, Shen Y, Liu J, Liu L, Du J,
Lei Y, Wen Y, Yang L, Guo L, et al: Genetic variants in HLA-DP/DQ
contribute to risk of cervical cancer: A two-stage study in Chinese
women. Gynecol Oncol. 129:401–405. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chen D, Juko-Pecirep I, Hammer J, Ivansson
E, Enroth S, Gustavsson I, Feuk L, Magnusson PK, McKay JD, Wilander
E and Gyllensten U: Genome-wide association study of susceptibility
loci for cervical cancer. J Natl Cancer Inst. 105:624–633. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wang SS, Gonzalez P, Yu K, Porras C, Li Q,
Safaeian M, Rodriguez AC, Sherman ME, Bratti C, Schiffman M, et al:
Common genetic variants and risk for HPV persistence and
progression to cervical cancer. PLoS One. 5:e86672010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kutler DI, Wreesmann VB, Goberdhan A,
Ben-Porat L, Satagopan J, Ngai I, Huvos AG, Giampietro P, Levran O,
Pujara K, et al: Human papillomavirus DNA and p53 polymorphisms in
squamous cell carcinomas from Fanconi anemia patients. J Natl
Cancer Inst. 95:1718–1721. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Park JW, Pitot HC, Strati K, Spardy N,
Duensing S, Grompe M and Lambert PF: Deficiencies in the Fanconi
anemia DNA damage response pathway increase sensitivity to
HPV-associated head and neck cancer. Cancer Res. 70:9959–9968.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Iarmarcovai G, Bonassi S, Botta A, Baan RA
and Orsière T: Genetic polymorphisms and micronucleus formation: a
review of the literature. Mutat Res. 658:215–33. 2008. View Article : Google Scholar
|
|
48
|
Skalka AM and Katz RA: Retroviral DNA
integration and the DNA damage response. Cell Death Differ.
12(Suppl 1): 971–978. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Thorland EC, Myers SL, Gostout BS and
Smith DI: Common fragile sites are preferential targets for HPV16
integrations in cervical tumors. Oncogene. 22:1225–1237. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Casper AM, Nghiem P, Arlt MF and Glover
TW: ATR regulates fragile site stability. Cell. 111:779–789. 2002.
View Article : Google Scholar
|
|
51
|
Arlt MF, Xu B, Durkin SG, Casper AM,
Kastan MB and Glover TW: BRCA1 is required for common-fragile-site
stability via its G2/M checkpoint function. Mol Cell Biol.
24:6701–6709. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Durkin SG, Arlt MF, Howlett NG and Glover
TW: Depletion of CHK1, but not CHK2, induces chromosomal
instability and breaks at common fragile sites. Oncogene.
25:4381–4388. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Glover TW, Arlt MF, Casper AM and Durkin
SG: Mechanisms of common fragile site instability. Hum Mol Genet.
14(Spec No. 2): R197–R205. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Housri N, Yarchoan R and Kaushal A:
Radiotherapy for patients with the human immunodeficiency virus:
Are special precautions necessary? Cancer. 116:273–283. 2010.
View Article : Google Scholar
|
|
55
|
Shrivastava SK, Engineer R, Rajadhyaksha S
and Dinshaw KA: HIV infection and invasive cervical cancers,
treatment with radiation therapy: Toxicity and outcome. Radiother
Oncol. 74:31–35. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Gichangi P, Bwayo J, Estambale B, Rogo K,
Njuguna E, Ojwang S and Temmerman M: HIV impact on acute morbidity
and pelvic tumor control following radiotherapy for cervical
cancer. Gynecol Oncol. 100:405–411. 2006. View Article : Google Scholar
|
